COST-EFFECTIVENESS OF DONEPEZIL IN THE TREATMENT OF PATIENTS WITH ALZHEIMER'S DISEASE: AN UPDATE

被引：0
|
作者：
Chyr, L. C. [1 ]
Yapici, H. O. [1 ]
Padula, W., V [1 ]
机构：
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.1399
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND26
引用
收藏
页码：S206 / S206
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness of screening and treating early Alzheimer's disease
    Araki, SS
    Kuntz, KM
    Neumann, PJ
    MEDICAL DECISION MAKING, 1998, 18 (04) : 456 - 456
  • [42] Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer's disease
    Lee, Spencer A. W.
    Sposato, Luciano A.
    Hachinski, Vladimir
    Cipriano, Lauren E.
    ALZHEIMERS RESEARCH & THERAPY, 2017, 9
  • [43] Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer’s disease
    Spencer A. W. Lee
    Luciano A. Sposato
    Vladimir Hachinski
    Lauren E. Cipriano
    Alzheimer's Research & Therapy, 9
  • [44] Addition of valproate to donepezil treatment in patients with Alzheimer's disease
    Borkowska, A.
    Tomaszewska, M.
    Wilkosc, M.
    Cichosz, A.
    Rybakowski, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S204 - S204
  • [45] Donepezil for the treatment of behavioral symptoms in patients with Alzheimer's disease
    Paleacu, D
    Mazeh, D
    Mirecki, I
    Even, M
    Barak, Y
    CLINICAL NEUROPHARMACOLOGY, 2002, 25 (06) : 313 - 317
  • [46] Donepezil Treatment for Alzheimer's Disease in Chronic Dialysis Patients
    Yiannopoulou, Konstantina G.
    Anastasiou, Aikaterini I.
    Kyrozis, Andreas
    Anastasiou, Ioannis P.
    CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 2019, 9 (03): : 126 - 136
  • [47] Anticoagulation Therapy for Atrial Fibrillation in Patients With Alzheimer's Disease A Cost-Effectiveness Analysis
    Vargas, Estefania Ruiz
    Sposato, Luciano A.
    Lee, Spencer A. W.
    Hachinski, Vladimir
    Cipriano, Lauren E.
    STROKE, 2018, 49 (12) : 2844 - 2850
  • [48] Cost-effectiveness of adding memantine treatment to patients receiving stabilised doses of donepezil in the UK
    Guilhaume, C
    Rive, B
    Cochran, J
    VALUE IN HEALTH, 2005, 8 (06) : A128 - A129
  • [49] COST-UTILITY ANALYSIS OF DONEPEZIL FOR THE TREATMENT OF ALZHEIMER'S DISEASE IN THAILAND
    Permsuwan, U.
    Niwatananun, W.
    Pimkrai, A.
    VALUE IN HEALTH, 2012, 15 (07) : A648 - A648
  • [50] Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy
    Sakka, Paraskevi
    Tsolaki, Magda
    Hort, Jakub
    Hager, Klaus
    Soininen, Hilkka
    Lopez Pousa, Secundino
    Li, Chunming
    Schwam, Elias
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (12) : 3153 - 3165
12345